Applied Therapeutics Inc (NASDAQ: APLT) on Friday, plunged -13.72% from the previous trading day, before settling in for the closing price of $1.02. Within the past 52 weeks, APLT’s price has moved between $0.95 and $10.62.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 1.41%. With a float of $87.26 million, this company’s outstanding shares have now reached $116.36 million.
In an organization with 25 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 378.67%, operating margin of 43736.49%, and the pretax margin is 88772.51%.
Applied Therapeutics Inc (APLT) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Applied Therapeutics Inc is 25.00%, while institutional ownership is 88.02%. The most recent insider transaction that took place on Aug 22 ’24, was worth 78,880. In this transaction Chief Financial Officer of this company sold 13,530 shares at a rate of $5.83, taking the stock ownership to the 277,911 shares. Before that another transaction happened on Aug 22 ’24, when Company’s Chief Medical Officer sold 22,681 for $5.83, making the entire transaction worth $132,230. This insider now owns 986,853 shares in total.
Applied Therapeutics Inc (APLT) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 1.41% per share during the next fiscal year.
Applied Therapeutics Inc (NASDAQ: APLT) Trading Performance Indicators
Applied Therapeutics Inc (APLT) is currently performing well based on its current performance indicators. A quick ratio of 1.06 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.29.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.32, a number that is poised to hit -0.20 in the next quarter and is forecasted to reach -0.59 in one year’s time.
Technical Analysis of Applied Therapeutics Inc (APLT)
Let’s dig in a bit further. During the last 5-days, its volume was 7.47 million. That was better than the volume of 2.66 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 17.44%. Additionally, its Average True Range was 0.49.
During the past 100 days, Applied Therapeutics Inc’s (APLT) raw stochastic average was set at 0.43%, which indicates a significant decrease from 4.60% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 89.45% in the past 14 days, which was lower than the 254.29% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.6278, while its 200-day Moving Average is $5.8416. However, in the short run, Applied Therapeutics Inc’s stock first resistance to watch stands at $0.9674. Second resistance stands at $1.0547. The third major resistance level sits at $1.1193. If the price goes on to break the first support level at $0.8155, it is likely to go to the next support level at $0.7509. Assuming the price breaks the second support level, the third support level stands at $0.6636.
Applied Therapeutics Inc (NASDAQ: APLT) Key Stats
Market capitalization of the company is 88.36 million based on 116,356K outstanding shares. Right now, sales total 9,990 K and income totals -119,760 K. The company made 120 K in profit during its latest quarter, and -68,590 K in sales during its previous quarter.
